A certificate of analysis showing 99 percent purity looks like a settled question. It is not, and treating it as one is a common way research protocols end up built on an assumption nobody actually checked: that the vial contains the compound its label says it does.
Key Takeaways
- HPLC purity testing measures how much of a sample is one dominant compound relative to impurities, but it does not confirm what that dominant compound actually is.
- Identity confirmation, typically by mass spectrometry, is a separate analytical step from purity testing, and both are needed for a complete picture.
- A sample can post a near-perfect HPLC purity result while being almost entirely the wrong molecule, if that molecule happens to co-elute cleanly.
- Independent third-party testing, distinct from a manufacturer’s own quality control, adds a layer of verification that catches errors a single lab might miss.
- Reading a certificate of analysis closely, checking for both purity and identity data, batch number, and testing method, takes a few minutes and closes a real gap in most bench-level checks.
The distinction sounds technical, but it has a concrete consequence. Two entirely different peptides can show similar retention behaviour on a given HPLC column under certain conditions, meaning a purity chromatogram alone cannot always distinguish “very pure sample of the intended compound” from “very pure sample of something else entirely.”
What HPLC Purity Testing Actually Measures
High-performance liquid chromatography separates the components of a sample based on how they interact with a column, then measures the relative proportion of each peak. A 99 percent purity figure means 99 percent of the detected material forms one dominant peak, which is a genuinely useful measurement, but it answers the question “how much of this sample is one thing” rather than “is that one thing what the label says.”
Industry testing services distinguish the two tests plainly: HPLC establishes purity by separating compounds and calculating the percentage of the target peak, while a separate identity test is needed to confirm what that peak actually corresponds to. Skipping the identity step and reading a purity percentage as a complete quality result is a documented and specific failure mode in peptide verification, not a hypothetical one.
The retention time a compound produces on a given HPLC column depends on its interaction with that column’s stationary phase, and structurally related peptides can sometimes interact with a column in similar ways under the same conditions. That is the practical reason a purity trace on its own is not proof of identity: the test was never designed to answer that question, and reading it as though it does is a misapplication of the method rather than a flaw in it.
A scientist conducting a laboratory experiment with sample vials
Why Identity Confirmation Is a Separate Step
Mass spectrometry, typically liquid chromatography coupled with mass spectrometry, confirms a compound’s identity by measuring its molecular mass and comparing it against the expected value for the intended peptide. This is a fundamentally different measurement from HPLC purity testing, and research into peptide identification methods treats mass-based confirmation as the standard route to reliably distinguishing one peptide sequence from another, particularly when structurally similar compounds are involved.
A purity result tells you how clean the sample is. An identity result tells you what the sample actually is. A certificate needs both to mean anything.
The practical implication for a research buyer is straightforward: a certificate of analysis that shows only an HPLC purity trace, with no accompanying mass spectrometry or equivalent identity data, has answered half the question. That gap is worth noticing before a compound goes anywhere near an experimental protocol, not after results come back difficult to explain.
Independent Testing as an Additional Check
A manufacturer’s own in-house testing is not inherently unreliable, but it is a single source checking its own output, and that has an obvious limitation. UK-based independent verification services exist specifically to add a second, unaffiliated set of results, using HPLC and mass spectrometry analysis under their own instrumentation and methods, which gives a researcher a check that does not depend on trusting one party’s quality process alone.
This matters more, not less, for suppliers who are transparent about it. A supplier willing to have batches independently checked, and to publish or share that documentation, is giving researchers grounds to trust a specific batch rather than the brand in the abstract. Peak Peptides UK documents batch-level purity and identity testing for products such as Retatrutide 20mg, giving researchers a specific record to review rather than a general quality claim to take on faith.
Researcher reviewing laboratory documentation and data on screen
What to Actually Look For on a Certificate
A complete certificate of analysis should tie a specific batch number to specific test results, not describe the compound generically. At minimum, that means a purity figure with the testing method stated, an identity confirmation result, and a date that lets a researcher judge how recently the batch was tested relative to when it was manufactured.
Missing any one of those elements does not automatically mean a problem exists. It means the certificate has not actually answered the question a researcher needs answered, which is worth flagging before the sample is used, not after.
It also helps to know which method produced each figure. A purity percentage generated by HPLC alone should be labelled as such, rather than presented in a way that implies broader verification than was actually performed. A certificate that names its methods clearly is easier to check against independent literature on what those methods can and cannot confirm, which is exactly the kind of cross-check a careful lab should be able to make without contacting the supplier first.
Laboratory glassware and equipment arranged on a research bench
Frequently Asked Questions
Can a peptide sample have high HPLC purity but still be the wrong compound?
Yes. HPLC purity measures the proportion of a sample forming one dominant peak, and it is possible, though not typical, for an incorrect compound to produce a clean, high-purity trace if it behaves similarly to the intended peptide under the test conditions used.
Is mass spectrometry always necessary alongside HPLC testing?
For confirming that a sample is genuinely the intended peptide, yes. HPLC alone establishes purity, not identity, and the two tests answer different questions that both matter for research reliability.
What does independent third-party testing add that manufacturer testing doesn’t?
It provides a result from a party with no stake in the manufacturer’s own quality claims, using separate instrumentation and analysts, which reduces the risk of a single testing process’s blind spots going unchecked.
Why does the batch number on a certificate of analysis matter?
Because purity and identity can vary slightly between manufacturing batches, a certificate tied to a specific batch number confirms the testing applies to the exact material received, not to the compound in general.
How recent should the testing date on a certificate be relative to when a sample is used?
There is no universal rule, but a testing date close to manufacture and supply gives more confidence than an old or undated certificate, since degradation risk increases the longer a sample sits before use.
Sources
- PeptideVerify: Peptide Verification and Testing UK, HPLC and LC-MS
- Rapid and Accurate Peptide Identification from Tandem Mass Spectra, PMC
- gov.uk: Borderline Products, How to Tell if Your Product Is a Medicine
- HPLC vs LC-MS in Peptide Verification, Lonestar Peptide Co